FACULTY
Angela C. Hirbe, MD, PhD
Associate Professor of Medicine and Pediatrics
Director, Adult Neurofibromatosis Clinical Program
Division of Oncology, Sarcoma Section
Washington University School of Medicine
St. Louis, MO
PROGRAM OVERVIEW
This enduring TeleECHO educational series focuses on neurofibromatosis 1 (NF1), a complex and heterogeneous genetic disorder with associated morbidities that significantly impair health-related quality of life. Engage with key experts in the field to improve knowledge regarding the pathophysiology of NF1 plexiform neurofibromas (NF1-PN) that have guided the investigation of targeted therapies which are revolutionizing the therapeutic landscape for both children and adults with symptomatic inoperable NF1-PN. Delve into in-depth discussions on case studies that bring real-world practical advice and involvement of comprehensive multidisciplinary care teams into the optimal care for patients to improve both their quality of life and disease outcomes.
TARGET AUDIENCE
This activity is designed to meet the educational needs of academic and community medical oncologists, neuro-oncologists, neurologists, surgical oncologists, neurosurgeons, advanced practice providers, and other healthcare providers who care for patients with NF1-PN.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Summarize key signs and symptoms of NF1-PN in adults
- Interpret clinical trial data on available and emerging therapeutic options for the treatment of NF1-PN
- Incorporate clinical practice recommendations for the use of systemic therapies for NF1-PN and mitigation of potential adverse events
- Cultivate comprehensive multidisciplinary care approaches for patients with NF1-PN
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Faculty | Relationship | Manufacturer |
Angela C. Hirbe, MD | Consultant | Aadi Bioscience, Inc, Alexion Pharmaceuticals, AstraZeneca, SpringWorks Therapeutics |
Licensing | Boehringer Ingelheim | |
Contracted Research | Tango Therapeutics | |
Honorarium | American Physician Institute of Advanced Professional Studies (API) |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Anita Misra-Press, PhD, Medical Director for Med Learning Group has nothing to disclose.
- Tom Bregartner, MBA, VP of Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Shannon Mutch MS, RN, OCN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Amanda Jenkins, Program Manager for Med Learning Group, has nothing to disclose.
- Daniel Dasilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, dietary, physical, etc). Please contact Med Learning Group prior to the enduring event at [email protected]
RELEASED DATE: July 11, 2025
EXPIRATION DATE: July 11, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.